Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! By
Cervical Cancer Screening Challenges Publisher



M Arab MALIHEH ; S Noeiteymoordash SOMAYYE ; Hrd Manshadi Hamid Reza DEHGHAN ; A Ghahghaeinezamabadi AKRAM ; M Motamedinasab MARYAM ; N Nouri NASIM
Authors

Source: Journal of Obstetrics, Gynecology and Cancer Research Published:2025


Abstract

Cervical cancer is one of the most common cancers among women all over the world. Most cases of cervical cancer occur in countries with limited resources. Screening in areas with rich facilities in people with moderate risk is done with cytology every three years, an HPV test, or both together (co-test) every five years. Screening starts at the age of 21 and ends at the age of 65, provided that the screening is sufficient and normal. In HIV-positive and immunocompromised people, at first visit cytology and colposcopy are performed, and then cytology is done every year; if it is negative three times, it continues every three years. In areas with limited facilities, it is recommended to start screening at the age of 30 for most cases, and depending on the test used, repeat the test every 3–10 years. If two consecutive screening results are negative, screening can be stopped at age 50. © 2025 Elsevier B.V., All rights reserved.
Other Related Docs
6. Lifetime Prevalence of Cervical Cancer Screening in 55 Low-And Middle-Income Countries, JAMA - Journal of the American Medical Association (2020)